(Press-News.org) Bottom Line: A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring CA19-9 levels alone.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).
Author: Kenneth S. Zaret, PhD, professor at the Perelman School of Medicine at the University of Pennsylvania.
Background: Pancreatic ductal adenocarcinoma (PDAC), which forms from the exocrine cells in the pancreas, is the most common form of pancreatic cancer, accounting for about 95% of cases. When detected at a localized, early stage, the five-year relative survival is about 44%, but once the disease has metastasized, the five-year survival drops to 3%. Most cases of pancreatic cancer are diagnosed at late stages.
“Pancreatic cancer usually doesn't present with symptoms until it's too late for surgery, when the cancer has already metastasized to other parts of the body,” said Zaret. “Our goal was to look for biomarkers in the blood that appear in early-stage PDAC patients, to catch the disease early,” he explained.
CA19-9 is a protein that is released into the blood by both cancer cells and normal pancreatic cells, and elevated levels of CA19-9 in the blood can be a sign of pancreatic cancer or other diseases. THBS2 is a protein that is expressed in PDAC tumor tissue, and when screened for in blood alongside CA19-9 using a bioassay, enables the test to better discriminate between PDAC and healthy patients, according to previous work from Zaret and colleagues. However, Zaret noted that these biomarkers are insufficient for routine early detection.
“CA19-9 is widely used to monitor diagnosed pancreatic cancer but isn’t recommended as a standalone screening test—benign conditions can elevate it in some people, while others may have low levels, even if they have pancreatic cancer. THBS2 is investigational and can complement CA19-9, but its prediagnostic performance has been mixed,” he said.
How the Study was Conducted: To identify novel biomarkers of pancreatic cancer, Zaret and colleagues analyzed plasma samples from two cohorts: 537 samples from the Mayo Clinic (Mayo) and 135 from the Hospital of the University of Pennsylvania (Penn). The cohorts included patients with confirmed pancreatic cancer, healthy individuals, and patients with benign pancreatic disease, which enabled the researchers to evaluate the ability of candidate biomarkers to differentiate between pancreatic cancer and benign conditions that could mimic cancer.
By comparing protein levels across the plasma samples, the researchers identified two proteins, ANPEP and PIGR, that showed elevated levels in samples from patients with early-stage PDAC, compared with samples from patients without cancer.
Zaret and colleagues then developed a panel that measured the blood levels of four biomarkers: the newly identified ANPEP and PIGR, along with the previously known biomarkers CA19-9 and THBS2.
Results: Across the two independent cohorts, Mayo and Penn, the four‑biomarker blood panel showed area under curve (AUC) values of 0.97 and 0.96, respectively, when comparing stage 1-2 PDAC and healthy controls. The AUC is a measure of the test’s ability to distinguish between two groups, with 1.0 being a perfect score.
The panel was also able to distinguish cancer from benign pancreatic conditions with an AUC 0.87 for early‑stage PDAC and 0.91 for all stages in the Mayo cohort.
The four-biomarker panel correctly detected 91.9% of pancreatic cancers across all stages and 87.5% of early‑stage cases, compared to testing for the CA19-9 biomarker alone, which identified 82.7% of the PDAC cases overall and 76.2% of the early-stage cases. The improvement in all-stage cancer detection was statistically significant, whereas the gain in early‑stage detection did not reach statistical significance in spite of the 11.3% improvement in sensitivity.
Authors’ Comments: If confirmed in larger, prospective studies, the four-biomarker blood panel could improve the ability to identify which individuals with a high risk for pancreatic cancer would benefit from follow-up imaging, explained Zaret, adding that this could allow clinicians to detect more pancreatic cancers at an earlier, more treatable stage.
“With the addition of ANPEP and PIGR, the panel helps to overcome known limitations associated with CA19-9 and THBS2 testing—such as patients who genetically underexpress CA19-9 or tumors that present as different molecular subtypes—and could therefore reduce the number of missed cancer cases while keeping false positives low,” he said.
Study Limitations: One limitation of this study is that the cohorts did not include individuals at increased risk for pancreatic cancer, such as those with a family history, germline BRCA mutations, or new-onset diabetes, introducing a bias in test performance, noted Zaret.
Another limitation is the retrospective nature of the study, which means that larger prospective studies are needed to confirm the panel’s real-world screening performance, Zaret explained.
Funding & Disclosures: The study was supported by the National Institutes of Health, Penn Pancreatic Cancer Research Center, A Love for Life, the Lustgarten Foundation, the Centene Foundation, and the Mayo Clinic Comprehensive Cancer Center. Zaret declares no conflicts of interest.
END
Investigational blood biomarker panel may improve detection of pancreatic cancer
2026-01-28
ELSE PRESS RELEASES FROM THIS DATE:
AAVLINK: Potent DNA-recombination method for large cargo delivery in gene therapy
2026-01-28
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying gene cargoes because of their superior gene segmentation flexibility and robust gene reconstitution efficiency. However, their limited packaging capacity is a major challenge for large gene transduction.
In a study published in Cell on Jan. 27, Prof. LU Zhonghua's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences, and collaborators from Peking University First ...
Treatment initiation is possible with a positive liquid biopsy in primary central nervous lymphoma patients with difficult-to-access lesions
2026-01-28
Niigata, Japan – A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed ten primary central nervous system lymphoma (PCNSL) patients who had difficult-to-access lesions in or around the brainstem, or were too frail to receive surgical biopsies. Hotspot MYD88 L265P mutations were detected from circulating tumor DNA (ctDNA) of cerebrospinal fluid (CSF) collected from lumbar taps in all patients.
A team led by Dr. Manabu Natsumeda successfully treated the patients after diagnosis by ...
Artificial nighttime lighting is suppressing moth activity
2026-01-28
Moths move significantly less when exposed to artificial nighttime light, new research shows.
Moths’ attraction to artificial light, such as streetlights, is common knowledge and has been much studied. But, as many people will have observed, moths may also remain still if they land near a light, apparently “trapped”.
To understand this behaviour, University of Exeter researchers caught more than 800 moths from 23 species and exposed them to LED lights (of various colours and brightness) or to natural night conditions.
Moths were collected with light traps and butterfly nets on the Penryn ...
What causes chronic pain? New study identifies key culprit in the brain
2026-01-28
A neural circuit hidden in an understudied region of the brain plays a critical role in turning temporary pain into pain that can last months or years, according to new University of Colorado Boulder research.
The animal study, published in the Journal of Neuroscience, found that silencing this pathway, known as the caudal granular insular cortex (CGIC), can prevent or halt chronic pain.
“Our paper used a variety of state-of-the art methods to define the specific brain circuit crucial for deciding ...
Counting the carbon cost of E-waste
2026-01-28
As the world upgrades to the latest gadgets, our old smartphones, refrigerators, and televisions are fueling the fastest-growing waste stream on the planet: E-waste. While recycling is often seen as a purely "green" endeavor, a groundbreaking study published in Carbon Research reveals that the process of dismantling these electronics carries its own significant carbon price tag.
Led by Dr. Mo Zhang from Nankai University, the research team provides the first comprehensive look at the carbon footprint of China’s E-waste dismantling industry. By meticulously tracking ...
Stanford research teams tackle environmental impacts of U.S. policy
2026-01-28
Federal priorities related to environmental protection, climate change, energy development, wildfire risk reduction, and the federal workforce have shifted rapidly over the past year, with potentially far-reaching consequences for ecosystems and public health. These changes represent a marked departure in U.S. policy direction and create an urgent need for research that can track how new policies are implemented and how their impacts unfold in real time. To help meet that need, the Stanford Woods Institute for the Environment has awarded special Environmental Venture ...
Grant to expand self-cloning crop technology for Indian farmers
2026-01-28
Venkatesan Sundaresan, a Distinguished Professor of plant biology and plant sciences at the University of California, Davis, has been awarded a Gates Foundation grant to develop self-cloning crops for Indian farmers. The five-year, $4.9 million project is a collaboration with researchers Myeong-Je Cho at UC Berkeley’s Innovative Genomics Institute (IGI), Viswanathan Chinnusamy at the ICAR-Indian Agricultural Research Institute (ICAR-IARI), New Delhi and Ravi Maruthachalam at the Indian Institutes of Science Education and Research (IISER-Thiruvananthapuram).
The ...
Atlantic nurse sharks show faster growth patterns in Biscayne Bay than nearby Bimini, Bahamas
2026-01-28
Atlantic nurse sharks show faster growth patterns in Biscayne Bay than nearby Bimini, Bahamas
A new study based on long-term monitoring data demonstrates significant differences in growth between nurse sharks off the coast of Miami and those living just across the Gulf Stream.
A new study from the University of Miami Rosenstiel School of Marine, Atmospheric, and Earth Science shows that juvenile Atlantic nurse sharks (Ginglymostoma cirratum) grow more rapidly as juveniles and reach smaller maximum sizes than nurse sharks in Bimini, Bahamas—locations so close that these populations have historically ...
Tests uncover unexpected humpback sensitivity to high-frequency noise
2026-01-28
University of Queensland hearing tests conducted across kilometres of ocean off the Australian coast show humpback whales react to higher frequency sounds than expected.
Associate Professor Rebecca Dunlop from UQ’s School of the Environment said the discovery has implications for the mitigation of noise-related human activity along whale migration routes.
“Until our studies, estimates of humpback hearing sensitivity were inferred based on the anatomy of their ears,” Dr Dunlop said.
“In a series of experiments off the Sunshine Coast, we exposed whales to upsweep sounds at a range of frequencies.
“We looked for changes such ...
Paracetamol and ibuprofen safe in first year of life
2026-01-28
A new landmark study supports the safety of the common painkillers paracetamol and ibuprofen in the first year of life, and finds no link to eczema or bronchiolitis, a common respiratory illness.
Previous research suggested a potential link between paracetamol use in the first year of life and later eczema, asthma and other diseases.
“Our study found that paracetamol and ibuprofen are incredibly safe to use in young children,” says lead researcher Professor Stuart Dalziel, Cure Kids Chair of Child Health Research at Waipapa Taumata Rau, University of Auckland, and Paediatrician at Starship Children’s Hospital.
Dalziel says paracetamol ...